Abolishing The Trailblazer Tax in Digital Medicine

Digital Medicine companies can often face disproportionate costs and challenges as they navigate uncharted regulatory territories, establish new reimbursement pathways, and educate stakeholders. 

This phenomenon, known as the "Trailblazer Tax," can hinder innovation and slow the adoption of potentially life-changing digital health solutions. As the industry matures, it's crucial to address this barrier and create a more equitable environment for both established players and new entrants.

Join us to discuss:

What are the most significant components of the Trailblazer Tax in digital medicine, and how can they be systematically addressed?

How can regulatory bodies and payers adapt their processes to reduce barriers for digital health innovators while maintaining necessary standards?

What role can established healthcare organizations and industry consortia play in helping to abolish the Trailblazer Tax for emerging digital health solutions?